Clinical Trial
Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management
- PMID: 3003037
Item in Clipboard
Clinical Trial
Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management
J Clin Psychiatry.
1986 Feb.
Abstract
Despite the plethora of clinical drug trials in tardive dyskinesia, few consistent findings have emerged. One possible reason for this is that there have been no serious attempts to define the role of major neurotransmitter systems (dopamine, norepinephrine, acetylcholine, serotonin, GABA) in one specific population of tardive dyskinesia patients. This study reports a series of five controlled drug trials in a population of patients with persistent tardive dyskinesia; each drug probed one of four neurotransmitter systems. The intra- and interpatient responses are analyzed and the implications of the pharmacologic response profiles for the clinical management of tardive dyskinesia are discussed.
Similar articles
-
Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings].Psychopharmacol Bull. 1978 Apr;14(2):20-2. Psychopharmacol Bull. 1978. PMID: 26102 Clinical Trial. No abstract available.
-
Sodium valproate in tardive dyskinesia.J Clin Psychiatry. 1979 Nov;40(11):483-5. J Clin Psychiatry. 1979. PMID: 385585
-
Oral choline administration to patients with tardive dyskinesia.N Engl J Med. 1977 Sep 8;297(10):524-7. doi: 10.1056/NEJM197709082971002. N Engl J Med. 1977. PMID: 887103 Clinical Trial.
-
[Physiopathology and curative treatment of tardive dyskinesia].Encephale. 1987 Sep-Oct;13(5):301-8. Encephale. 1987. PMID: 2892663 Review. French.
-
Use of choline and lecithin in the treatment of tardive dyskinesia.Adv Biochem Psychopharmacol. 1980;24:463-70. Adv Biochem Psychopharmacol. 1980. PMID: 6996444 Review. No abstract available.
Cited by
-
Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.Cochrane Database Syst Rev. 2018 Apr 17;4(4):CD000203. doi: 10.1002/14651858.CD000203.pub4. Cochrane Database Syst Rev. 2018. PMID: 29663328 Free PMC article. Review.
-
Cholinergic medication for antipsychotic-induced tardive dyskinesia.Cochrane Database Syst Rev. 2018 Mar 19;3(3):CD000207. doi: 10.1002/14651858.CD000207.pub2. Cochrane Database Syst Rev. 2018. PMID: 29553158 Free PMC article. Review.
-
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.Cochrane Database Syst Rev. 2018 Mar 19;3(3):CD000208. doi: 10.1002/14651858.CD000208.pub2. Cochrane Database Syst Rev. 2018. PMID: 29552749 Free PMC article. Review.
-
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.Cochrane Database Syst Rev. 2018 Jan 18;1(1):CD000458. doi: 10.1002/14651858.CD000458.pub3. Cochrane Database Syst Rev. 2018. PMID: 29342497 Free PMC article. Review.
-
Valproate for schizophrenia.Cochrane Database Syst Rev. 2016 Nov 24;11(11):CD004028. doi: 10.1002/14651858.CD004028.pub4. Cochrane Database Syst Rev. 2016. PMID: 27884042 Free PMC article. Review.